SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:SYN

<< 이전 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2017/01/19	07:05	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:SYN	Synthetic Biologics Inc
2017/01/19	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2017/01/19	06:09	PR Newswire (US)	Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA	AMEX:SYN	Synthetic Biologics Inc
2017/01/12	23:24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	AMEX:SYN	Synthetic Biologics Inc
2017/01/09	21:03	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2017/01/05	21:06	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2017/01/05	20:58	PR Newswire (US)	Synthetic Biologics' SYN-004 (ribaxamase) Achieves Primary Endpoint in Phase 2b Trial for C. difficile Infection (CDI)	AMEX:SYN	Synthetic Biologics Inc
2017/01/03	20:58	PR Newswire (US)	Synthetic Biologics to Present at the Biotech Showcase™ 2017 Conference	AMEX:SYN	Synthetic Biologics Inc
2016/12/13	20:58	PR Newswire (US)	Synthetic Biologics Announces Granting of U.S. Composition of Matter Patent for SYN-005, Designed for the Treatment and Preve...	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/12/03	07:02	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2016/12/01	21:00	PR Newswire (US)	Synthetic Biologics Announces Participation in Two Upcoming Investor Conferences	AMEX:SYN	Synthetic Biologics Inc
2016/11/19	01:43	PR Newswire (US)	Synthetic Biologics Announces Closing of Public Offering of Common Stock and Warrants	AMEX:SYN	Synthetic Biologics Inc
2016/11/19	01:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYN	Synthetic Biologics Inc
2016/11/18	03:03	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:SYN	Synthetic Biologics Inc
2016/11/16	07:15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:SYN	Synthetic Biologics Inc
2016/11/16	07:13	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2016/11/15	23:08	PR Newswire (US)	Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants	AMEX:SYN	Synthetic Biologics Inc
2016/11/15	20:17	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:SYN	Synthetic Biologics Inc
2016/11/15	06:05	PR Newswire (US)	Synthetic Biologics Announces Commencement of Public Offering of Common Stock and Warrants	AMEX:SYN	Synthetic Biologics Inc
2016/11/01	20:13	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:SYN	Synthetic Biologics Inc
2016/11/01	20:06	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:SYN	Synthetic Biologics Inc
2016/11/01	19:58	PR Newswire (US)	Synthetic Biologics Reports Third Quarter 2016 Operational Highlights and Financial Results	AMEX:SYN	Synthetic Biologics Inc
2016/10/25	19:58	PR Newswire (US)	Synthetic Biologics to Report Third Quarter 2016 Operational Highlights and Financial Results on November 1, 2016	AMEX:SYN	Synthetic Biologics Inc
2016/10/06	19:58	PR Newswire (US)	Synthetic Biologics Awarded Research Contract from Centers for Disease Control and Prevention (CDC) for Microbiome Assessment...	AMEX:SYN	Synthetic Biologics Inc
2016/09/20	19:58	PR Newswire (US)	Synthetic Biologics Announces Completion of Enrollment for Phase 2b Proof-of-Concept Clinical Trial for SYN-004 (ribaxamase) ...	AMEX:SYN	Synthetic Biologics Inc